154 related articles for article (PubMed ID: 37213298)
1. High-frequency irreversible electroporation improves survival and immune cell infiltration in rodents with malignant gliomas.
Campelo SN; Lorenzo MF; Partridge B; Alinezhadbalalami N; Kani Y; Garcia J; Saunier S; Thomas SC; Hinckley J; Verbridge SS; Davalos RV; Rossmeisl JH
Front Oncol; 2023; 13():1171278. PubMed ID: 37213298
[TBL] [Abstract][Full Text] [Related]
2. Comparison between high-frequency irreversible electroporation and irreversible electroporation ablation of small swine liver: follow-up of DCE-MRI and pathological observations.
Li J; Zhang XB; Wang JJ; Jin LJ; Shan HS; Zhang X; Ma L; Xue XD; Zhang X; Zhang ZL; Meng LL; Yuan F; Xiao YY
Chin Med J (Engl); 2021 Jun; 134(17):2081-2090. PubMed ID: 34172620
[TBL] [Abstract][Full Text] [Related]
3. Lethal Electric Field Thresholds for Cerebral Cells With Irreversible Electroporation and H-FIRE Protocols: An In Vitro Three-Dimensional Cell Model Study.
Shu T; Ding L; Fang Z; Yu S; Chen L; Moser MAJ; Zhang W; Qin Z; Zhang B
J Biomech Eng; 2022 Oct; 144(10):. PubMed ID: 35445240
[TBL] [Abstract][Full Text] [Related]
4. The Accumulation and Effects of Liposomal Doxorubicin in Tissues Treated by Radiofrequency Ablation and Irreversible Electroporation in Liver: In Vivo Experimental Study on Porcine Models.
Andrašina T; Jaroš J; Jůza T; Rohan T; Červinka D; Crha M; Válek V; Goldberg NS
Cardiovasc Intervent Radiol; 2019 May; 42(5):751-762. PubMed ID: 30761413
[TBL] [Abstract][Full Text] [Related]
5. High-Frequency Irreversible Electroporation (H-FIRE) Induced Blood-Brain Barrier Disruption Is Mediated by Cytoskeletal Remodeling and Changes in Tight Junction Protein Regulation.
Partridge BR; Kani Y; Lorenzo MF; Campelo SN; Allen IC; Hinckley J; Hsu FC; Verbridge SS; Robertson JL; Davalos RV; Rossmeisl JH
Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740406
[TBL] [Abstract][Full Text] [Related]
6. High-frequency irreversible electroporation (H-FIRE) for non-thermal ablation without muscle contraction.
Arena CB; Sano MB; Rossmeisl JH; Caldwell JL; Garcia PA; Rylander MN; Davalos RV
Biomed Eng Online; 2011 Nov; 10():102. PubMed ID: 22104372
[TBL] [Abstract][Full Text] [Related]
7. Temperature Dependence of High Frequency Irreversible Electroporation Evaluated in a 3D Tumor Model.
Fesmire CC; Petrella RA; Fogle CA; Gerber DA; Xing L; Sano MB
Ann Biomed Eng; 2020 Aug; 48(8):2233-2246. PubMed ID: 32409902
[TBL] [Abstract][Full Text] [Related]
8. Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an orthotopic model.
Shankara Narayanan JS; Hayashi T; Erdem S; McArdle S; Tiriac H; Ray P; Pu M; Mikulski Z; Miller A; Messer K; Carson D; Schoenberger S; White RR
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36634919
[TBL] [Abstract][Full Text] [Related]
9. High-frequency irreversible electroporation is an effective tumor ablation strategy that induces immunologic cell death and promotes systemic anti-tumor immunity.
Ringel-Scaia VM; Beitel-White N; Lorenzo MF; Brock RM; Huie KE; Coutermarsh-Ott S; Eden K; McDaniel DK; Verbridge SS; Rossmeisl JH; Oestreich KJ; Davalos RV; Allen IC
EBioMedicine; 2019 Jun; 44():112-125. PubMed ID: 31130474
[TBL] [Abstract][Full Text] [Related]
10. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
[TBL] [Abstract][Full Text] [Related]
11. High-frequency irreversible electroporation brain tumor ablation: exploring the dynamics of cell death and recovery.
Murphy KR; Aycock KN; Hay AN; Rossmeisl JH; Davalos RV; Dervisis NG
Bioelectrochemistry; 2022 Apr; 144():108001. PubMed ID: 34844040
[TBL] [Abstract][Full Text] [Related]
12. Burst and continuous high frequency irreversible electroporation protocols evaluated in a 3D tumor model.
Sano MB; Fesmire CC; DeWitt MR; Xing L
Phys Med Biol; 2018 Jul; 63(13):135022. PubMed ID: 29978834
[TBL] [Abstract][Full Text] [Related]
13. Cardiac impact of high-frequency irreversible electroporation using an asymmetrical waveform on liver in vivo.
Li J; Wang J; Zhang X; Zhang X; Gao H; Xiao Y
BMC Cardiovasc Disord; 2021 Dec; 21(1):581. PubMed ID: 34876030
[TBL] [Abstract][Full Text] [Related]
14. Experimental and Numerical Investigation of Parameters Affecting High-Frequency Irreversible Electroporation for Prostate Cancer Ablation.
Aycock KN; Vadlamani RA; Jacobs EJ; Imran KM; Verbridge SS; Allen IC; Manuchehrabadi N; Davalos RV
J Biomech Eng; 2022 Jun; 144(6):. PubMed ID: 35044426
[TBL] [Abstract][Full Text] [Related]
15. High-Frequency Irreversible Electroporation: Safety and Efficacy of Next-Generation Irreversible Electroporation Adjacent to Critical Hepatic Structures.
Siddiqui IA; Kirks RC; Latouche EL; DeWitt MR; Swet JH; Baker EH; Vrochides D; Iannitti DA; Davalos RV; McKillop IH
Surg Innov; 2017 Jun; 24(3):276-283. PubMed ID: 28492356
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of Cell Death After Conventional IRE and H-FIRE Treatments.
Mercadal B; Beitel-White N; Aycock KN; Castellví Q; Davalos RV; Ivorra A
Ann Biomed Eng; 2020 May; 48(5):1451-1462. PubMed ID: 32026232
[TBL] [Abstract][Full Text] [Related]
17. Treating glioblastoma multiforme with selective high-dose liposomal doxorubicin chemotherapy induced by repeated focused ultrasound.
Yang FY; Teng MC; Lu M; Liang HF; Lee YR; Yen CC; Liang ML; Wong TT
Int J Nanomedicine; 2012; 7():965-74. PubMed ID: 22393293
[TBL] [Abstract][Full Text] [Related]
18. High-frequency irreversible electroporation targets resilient tumor-initiating cells in ovarian cancer.
Rolong A; Schmelz EM; Davalos RV
Integr Biol (Camb); 2017 Dec; 9(12):979-987. PubMed ID: 29186222
[TBL] [Abstract][Full Text] [Related]
19. Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts.
Yamashita Y; Krauze MT; Kawaguchi T; Noble CO; Drummond DC; Park JW; Bankiewicz KS
Neuro Oncol; 2007 Jan; 9(1):20-8. PubMed ID: 17018695
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
